Lilly antibody drug fails in a COVID-19 study; others go on

Lilly antibody drug fails in a COVID-19 study; others go on

U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to be helping them. Independent monitors had paused enrollment in the study two weeks ago …
See Original Article

Kentucky breweries working with local farms to create Kentucky Proud Beer

LEXINGTON, Ky. (WTVQ) – This year’s Kentucky Proud Beer Series begins Wednesday, the focus is creating Kentucky Proud Beer with Kentucky agriculture. “Just, you know, seeing your product go into beer and bourbon.” The beer series is a staple of …
See Original Article

Corvee releases forward-looking tax planning software

“There is currently nothing like this software available to tax and accounting professionals, and we are thrilled to be the first to offer this to our clients
See Original Article

HomeStreet: 3Q Earnings Snapshot

SEATTLE (AP) _ HomeStreet Inc. (HMST) on Monday reported third-quarter profit of $26.3 million. The Seattle-based company said it had profit of $1.15 per share. Earnings, adjusted for restructuring costs, came to $1.23 per share. The results topped Wall …
See Original Article

'New' Medtronic Wins FDA Approval for Venous Self-Expanding Stent System

Medtronic has been awarded FDA approval for a device that treats venous outflow obstruction. The Dublin-based company’s Abre venous self-expanding stent system is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous …
See Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.